Literature DB >> 11289329

Correlation between airway hyperresponsiveness and airway inflammation in a young adult population: eosinophil, ECP, and cytokine levels in induced sputum.

Y Obase1, T Shimoda, K Mitsuta, N Matsuo, H Matsuse, S Kohno.   

Abstract

BACKGROUND: Eosinophil counts and eosinophil cationic protein (ECP) levels in the airway are elevated in asthmatic patients. However, few studies have examined the correlation between various cytokines in the sputum and airway hyperresponsiveness (AHR) in young adults with or without asthma.
OBJECTIVE: We examined the correlation between AHR and eosinophil counts or ECP, and levels of several cytokines in the sputum.
METHODS: We studied 120 nonsmoker students (group 1: intermittent mild asthmatic patients; group 2: subjects with history of childhood asthma; group 3: subjects sensitized by Dermatophagoides farinae with atopic disease; group 4: normal subjects sensitized by D. farinae; group 5: subjects with cedar pollinosis; and group 6: normal subjects). In each subject, AHR and lung function tests were measured, together with eosinophil count, ECP, granulocyte-macrophage colony-stimulating factor, TNF-alpha, IL-5, and interleukin-1beta in induced sputum.
RESULTS: AHR in groups 1 and group 2 were high, in groups 5 and 6 low, and in groups 3 and 4 lower than in groups 1 and 2 but higher than groups 5 and 6. Percentages of eosinophils, ECP, and TNF-alpha in induced sputum in groups 1 and 2 were high, those in groups 5 and 6 were below detection limits, and those in groups 3 and 4 were lower than the percentages in groups 1 and 2. Granulocyte-macrophage colony-stimulating factor in the sputum was elevated only in group 1. The correlations between AHR and sputum eosinophil count, ECP, and TNF-alpha were significant, with the strongest correlation with TNF-alpha.
CONCLUSIONS: Our results suggest that TNF-alpha levels in the sputum play an important role in determining the severity of AHR in young individuals. Further once AHR develops, it does not disappear, and the severity of airway inflammation influences the extent of AHR.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11289329     DOI: 10.1016/S1081-1206(10)63303-0

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  14 in total

1.  Linking ventilation heterogeneity and airway hyperresponsiveness in asthma.

Authors:  Jose Venegas
Journal:  Thorax       Date:  2007-08       Impact factor: 9.139

2.  Genetic polymorphisms of the TNF-α-308G/A are associated with metabolic syndrome in asthmatic patients from Hebei province, China.

Authors:  Yong-Hui Yang; Yan-Qin Liu; Ling Zhang; Hui Li; Xing-Bin Li; Qin Ouyang; Gui-Yun Zhu
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

Review 3.  Modeling TH 2 responses and airway inflammation to understand fundamental mechanisms regulating the pathogenesis of asthma.

Authors:  Paul S Foster; Steven Maltby; Helene F Rosenberg; Hock L Tay; Simon P Hogan; Adam M Collison; Ming Yang; Gerard E Kaiko; Philip M Hansbro; Rakesh K Kumar; Joerg Mattes
Journal:  Immunol Rev       Date:  2017-07       Impact factor: 12.988

4.  Effect of tumor necrosis factor-α antagonism in asthma: a meta-analysis of the published literature.

Authors:  Xiaoju Chen; Liang Xiong; Shouming Qin; Wanli Ma; Qiong Zhou
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-02-19

5.  Ventilation heterogeneity is a major determinant of airway hyperresponsiveness in asthma, independent of airway inflammation.

Authors:  Sue R Downie; Cheryl M Salome; Sylvia Verbanck; Bruce Thompson; Norbert Berend; Gregory G King
Journal:  Thorax       Date:  2007-02-20       Impact factor: 9.139

6.  Perinatal tumor necrosis factor-α production, influenced by maternal pregnancy weight gain, predicts childhood asthma.

Authors:  Marilyn Halonen; I Carla Lohman; Debra A Stern; Whitney L Ellis; Janet Rothers; Anne L Wright
Journal:  Am J Respir Crit Care Med       Date:  2013-07-01       Impact factor: 21.405

Review 7.  Severe asthma.

Authors:  Nicholas J Kenyon; Nizar N Jarjour
Journal:  Clin Rev Allergy Immunol       Date:  2003-10       Impact factor: 8.667

8.  Preclinical development of CAT-354, an IL-13 neutralizing antibody, for the treatment of severe uncontrolled asthma.

Authors:  R D May; P D Monk; E S Cohen; D Manuel; F Dempsey; N H E Davis; A J Dodd; D J Corkill; J Woods; C Joberty-Candotti; L A Conroy; F Koentgen; E C Martin; R Wilson; N Brennan; J Powell; I K Anderson
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

9.  Eosinophilic inflammation in allergic asthma.

Authors:  Samantha S Possa; Edna A Leick; Carla M Prado; Mílton A Martins; Iolanda F L C Tibério
Journal:  Front Pharmacol       Date:  2013-04-17       Impact factor: 5.810

10.  Inhaled corticosteroid effects both eosinophilic and non-eosinophilic inflammation in asthmatic patients.

Authors:  Ilknur Basyigit; Fusun Yildiz; Sevgiye Kacar Ozkara; Hasim Boyaci; Ahmet Ilgazli
Journal:  Mediators Inflamm       Date:  2004-08       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.